Clinical Trial Details
EORTC-40873
Back to Clinical Trials Database
Phase II clinical trial of epirubicin and cisplatin (EP) in combination with a split cause radiotherapy plus 5-Fluorouracil in locally advanced unresectable pancreatic cancer.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Nov-1987 Date Step1 close: 01-Mar-1992 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 30 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
